Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Cross Country Healthcare (CCRN) Gets a Hold from Truist Financial

Tipranks - Tipranks - Tue Oct 14, 2025

In a report released today, Tobey Sommer from Truist Financial maintained a Hold rating on Cross Country Healthcare. The company’s shares closed last Friday at $11.59.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

According to TipRanks, Sommer is a 5-star analyst with an average return of 8.6% and a 61.65% success rate. Sommer covers the Industrials sector, focusing on stocks such as Clean Harbors, Huron Consulting, and KBR.

Currently, the analyst consensus on Cross Country Healthcare is a Hold with an average price target of $13.00, a 12.17% upside from current levels. In a report released on October 3, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a $13.00 price target.

See today’s best-performing stocks on TipRanks >>

Based on Cross Country Healthcare’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $274.07 million and a GAAP net loss of $6.66 million. In comparison, last year the company earned a revenue of $339.77 million and had a GAAP net loss of $16.05 million

Read More on CCRN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).